About This Event
PRESIDENT'S EVENT SERIES
THURSDAY, November 6 | 6 PM
Fearless: Critical Conversations on the Future of American Science
For decades, the United States has been the global leader in medical innovation, developing cures and treatments that have saved millions of lives. But is that leadership guaranteed for the future?
Join HMRI for a deliberately provocative look at the future of American medical research. We will ask the critical question: In 2050, does the U.S. still lead the world in curing disease? Or are our children traveling abroad for lifesaving treatments we failed to develop?
This President's Event Series panel discussion will convene leading voices from science, policy, and industry to explore the structural threats and opportunities facing U.S. medical innovation.
Featuring
Dr. Scott A. Kaiser MD
Dr. Scott Kaiser is a board-certified family physician and geriatrician whose work bridges medicine, innovation, and social impact. As CEO and co-founder of Determined Health, he leads efforts to improve well-being and strengthen community connection through preventive and personalized care. A recognized voice in aging and population health, he also serves on the Board of Directors of the BrightFocus Foundation, supporting research to end Alzheimer’s disease, macular degeneration, and glaucoma.
Dr. Shlomo Melmed, MBChB
Dr. Shlomo Melmed, dean of the Medical Faculty at Cedars Sinai Medical Center and distinguished professor of Medicine. Melmed has been a faculty leader at Cedars‑Sinai for 45 years and has been the health system’s chief academic officer since 1998. At Cedars-Sinai, he has shepherded the highest nationally ranked systemwide programs with a sustained impact on the practice of medicine by his clinical leadership and translational endocrinology discoveries. An international authority on pituitary medicine, he has pioneered the discovery and application of novel treatments for endocrine tumors and has authored more than 400 peer-reviewed articles in prestigious journals.
Dr. Angelika Niemz, PhD
Dr. Angelika Niemz is dean of the Henry E. Riggs School of Applied Life Sciences at Keck Graduate Institute (KGI) and a faculty member dedicated to advancing interdisciplinary education and research in biotechnology. Over more than two decades at KGI, she has led pioneering work in medical diagnostics, biomarker discovery, and biotechnology training supported by the National Science Foundation, National Institutes of Health, and Department of Defense. Originally from Germany, she earned her PhD in chemistry from the University of Massachusetts Amherst and conducted postdoctoral research at Caltech before joining KGI in 2002.
Moderated by Dr. Julia Bradsher, PhD, MBA
As President & CEO of Huntington Medical Research Institutes, Julia Bradsher leads groundbreaking work in neurosciences, cardiovascular health, and aging. With more than 25 years of executive leadership - including 16 years as a CEO - she’s guided organizations through transformation, growth, and complex strategic challenges.
About This Event
PRESIDENT'S EVENT SERIES
THURSDAY, November 6 | 6 PM
Fearless: Critical Conversations on the Future of American Science
For decades, the United States has been the global leader in medical innovation, developing cures and treatments that have saved millions of lives. But is that leadership guaranteed for the future?
Join HMRI for a deliberately provocative look at the future of American medical research. We will ask the critical question: In 2050, does the U.S. still lead the world in curing disease? Or are our children traveling abroad for lifesaving treatments we failed to develop?
This President's Event Series panel discussion will convene leading voices from science, policy, and industry to explore the structural threats and opportunities facing U.S. medical innovation.
Featuring
Dr. Scott A. Kaiser MD
Dr. Scott Kaiser is a board-certified family physician and geriatrician whose work bridges medicine, innovation, and social impact. As CEO and co-founder of Determined Health, he leads efforts to improve well-being and strengthen community connection through preventive and personalized care. A recognized voice in aging and population health, he also serves on the Board of Directors of the BrightFocus Foundation, supporting research to end Alzheimer’s disease, macular degeneration, and glaucoma.
Dr. Shlomo Melmed, MBChB
Dr. Shlomo Melmed, dean of the Medical Faculty at Cedars Sinai Medical Center and distinguished professor of Medicine. Melmed has been a faculty leader at Cedars‑Sinai for 45 years and has been the health system’s chief academic officer since 1998. At Cedars-Sinai, he has shepherded the highest nationally ranked systemwide programs with a sustained impact on the practice of medicine by his clinical leadership and translational endocrinology discoveries. An international authority on pituitary medicine, he has pioneered the discovery and application of novel treatments for endocrine tumors and has authored more than 400 peer-reviewed articles in prestigious journals.
Dr. Angelika Niemz, PhD
Dr. Angelika Niemz is dean of the Henry E. Riggs School of Applied Life Sciences at Keck Graduate Institute (KGI) and a faculty member dedicated to advancing interdisciplinary education and research in biotechnology. Over more than two decades at KGI, she has led pioneering work in medical diagnostics, biomarker discovery, and biotechnology training supported by the National Science Foundation, National Institutes of Health, and Department of Defense. Originally from Germany, she earned her PhD in chemistry from the University of Massachusetts Amherst and conducted postdoctoral research at Caltech before joining KGI in 2002.
Moderated by Dr. Julia Bradsher, PhD, MBA
As President & CEO of Huntington Medical Research Institutes, Julia Bradsher leads groundbreaking work in neurosciences, cardiovascular health, and aging. With more than 25 years of executive leadership - including 16 years as a CEO - she’s guided organizations through transformation, growth, and complex strategic challenges.